Hospital Master - National Seeds Corporation Limited
S.No. HOSPITALNAME. STREET. CITYDESC. STATEDESC. PINCODE. 1 Highway Hospital. Dev Ashish Jeen Hath Naka, Maarathon Circle. Mumbai and. Suburb. Maharashtra. 
??0???????. ???????????????????????????????????????. ????????????????????????????????????? folio_demat_id - ManappuramFOLIO_DEMAT_ID. NAME. Add1. Add2. Add3. City. PIN. NETDIV. 1203280000558584. MOHD MUJTABA ALI . PO BOX 22112 . 0. 11.00. 1208160000263589. ASHISH BHASIN. VIDAL HEALTH TPA NETWORK HOSPITALS LIST_.pdfAndhra Pradesh. Guntur. HOS-HYD-1335. St. Joseph'S General Hospital. 522004. 0863-2322700. Andhra Pradesh. Guntur. HOS-HYD-1726. Sudarsani Eye Hospital. VIDAL - NETWORK HOSPITAL LIST - NLC India#15-455, Near Srs Lodge, Kamala. Nagar. 515001. 040-66136238. Andhra Pradesh. Ananthapur. Dr Ysr Memorial Hospital. #12-2-878, 1Cross, Sai Nagar. Kenshingakuen ???? The English Version of the New ...Kenshingakuen. ????. The English Version of the New Interpretation of. Teaching, Practice, Faith, and Enlightenment. ???????????? ???????????? ?? ????????? ???????-?????????? ...????????? ????, f das Einzel 196 ????????? ??????, f das ... ????????????, f der Neustart 174 ??????????? ?????, f die Querlatte 190. INSTALLATION GUIDE - VIZIO Untitled - River Campus LibrariesThe toughs of the party, men like Longo and Secchia, long straining at the leash, are being let loose with explicit instruction to sabo- tage the Marshall Plan. Zydus Wellness Ltd. - HDFC securitiesPursuant to regulations 30 and 46(2)(oa) of the Listing Regulations, please find attached the transcript of the Company's Q2 FY25 post results ... Zydus Lifesciences Limited Q2 FY25 Post Results Earnings CallIn this Annual Report, we may have disclosed forward-looking information to enable stakeholders to comprehend our prospects and take ... 2023-2024 - Zydus Lifesciencesa rolled over target price of Rs. 1,196, based on 27x FY26E adjusted EPS. Company Data. Market Cap (cr). Rs.109,524. Enterprise Value (cr). Rs.112,585. Zydus Lifesciences LimitedZYDUSLIF trades at 22.6x FY26E and 25.2x. FY27E core P/E. We reiterate BUY with TP at INR 1,311 (33x FY27E core earnings plus cash per share).
